These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36690926)

  • 1.
    Kim JS; Manichaikul AW; Hoffman EA; Balte P; Anderson MR; Bernstein EJ; Madahar P; Oelsner EC; Kawut SM; Wysoczanski A; Laine AF; Adegunsoye A; Ma JZ; Taub MA; Mathias RA; Rich SS; Rotter JI; Noth I; Garcia CK; Barr RG; Podolanczuk AJ
    Thorax; 2023 Jun; 78(6):566-573. PubMed ID: 36690926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length and genetic variant associations with interstitial lung disease progression and survival.
    Newton CA; Oldham JM; Ley B; Anand V; Adegunsoye A; Liu G; Batra K; Torrealba J; Kozlitina J; Glazer C; Strek ME; Wolters PJ; Noth I; Garcia CK
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30635297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of hiatus hernia with CT-based interstitial lung changes: the MESA Lung Study.
    Kim JS; Kim J; Yin X; Hiura GT; Anderson MR; Hoffman EA; Raghu G; Noth I; Manichaikul A; Rich SS; Smith BM; Podolanczuk AJ; Garcia CK; Barr RG; Prince MR; Oelsner EC
    Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 35777776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
    Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
    Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of visual and quantitative methods to identify interstitial lung abnormalities.
    Kliment CR; Araki T; Doyle TJ; Gao W; Dupuis J; Latourelle JC; Zazueta OE; Fernandez IE; Nishino M; Okajima Y; Ross JC; Estépar RS; Diaz AA; Lederer DJ; Schwartz DA; Silverman EK; Rosas IO; Washko GR; O'Connor GT; Hatabu H; Hunninghake GM
    BMC Pulm Med; 2015 Oct; 15():134. PubMed ID: 26514822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC5B promoter polymorphism and interstitial lung abnormalities.
    Hunninghake GM; Hatabu H; Okajima Y; Gao W; Dupuis J; Latourelle JC; Nishino M; Araki T; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Murphy E; Steele MP; Loyd JE; Schwarz MI; Fingerlin TE; Rosas IO; Washko GR; O'Connor GT; Schwartz DA
    N Engl J Med; 2013 Jun; 368(23):2192-200. PubMed ID: 23692170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.
    McDermott G; Gill R; Gagne S; Byrne S; Huang W; Cui J; Prisco L; Zaccardelli A; Martin L; Kronzer VL; Moll M; Cho MH; Shadick N; Dellaripa PF; Doyle T; Sparks JA
    Rheumatology (Oxford); 2022 Nov; 61(12):4915-4923. PubMed ID: 35289841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
    Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
    Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
    Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
    Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Joo YB; Ahn SM; Bang SY; Park Y; Hong SJ; Lee Y; Cho SK; Choi CB; Sung YK; Kim TH; Jun JB; Yoo DH; Bae SC; Lee HS
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36581384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
    Adegunsoye A; Vij R; Noth I
    Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.
    Volkmann ER; Tashkin DP; Roth MD; Li N; Charles J; Mayes M; Kim G; Goldin J; Pourzand L; Clements PJ; Furst DE; Khanna D; Elashoff RM; Assassi S
    Semin Arthritis Rheum; 2020 Oct; 50(5):963-967. PubMed ID: 32906032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive Sleep Apnea and Longitudinal Changes in Interstitial Lung Imaging and Lung Function: The MESA Study.
    Kim JS; Azarbarzin A; Podolanczuk AJ; Anderson MR; Cade BE; Kawut SM; Wysoczanski A; Laine AF; Hoffman EA; Gottlieb DJ; Garcia CK; Barr RG; Redline S
    Ann Am Thorac Soc; 2023 May; 20(5):728-737. PubMed ID: 36790913
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum 25-Hydroxyvitamin D Concentrations Are Associated with Computed Tomography Markers of Subclinical Interstitial Lung Disease among Community-Dwelling Adults in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Kim SM; Zhao D; Podolanczuk AJ; Lutsey PL; Guallar E; Kawut SM; Barr RG; de Boer IH; Kestenbaum BR; Lederer DJ; Michos ED
    J Nutr; 2018 Jul; 148(7):1126-1134. PubMed ID: 29931068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in
    Palomäki A; ; Palotie A; Koskela J; Eklund KK; Pirinen M; ; Ripatti S; Laitinen T; Mars N
    Ann Rheum Dis; 2021 Dec; 80(12):1530-1536. PubMed ID: 34344703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
    Salisbury ML; Hewlett JC; Ding G; Markin CR; Douglas K; Mason W; Guttentag A; Phillips JA; Cogan JD; Reiss S; Mitchell DB; Wu P; Young LR; Lancaster LH; Loyd JE; Humphries SM; Lynch DA; Kropski JA; Blackwell TS
    Am J Respir Crit Care Med; 2020 May; 201(10):1230-1239. PubMed ID: 32011901
    [No Abstract]   [Full Text] [Related]  

  • 20. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
    Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
    Transpl Int; 2022; 35():10159. PubMed ID: 35651878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.